Quince Therapeutics, Inc.
SEC Filing List
QNCX CIK: 0001662774
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K/A | Amendment to Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/26/2026 | |
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/26/2026 | |
| 4 | Statement of changes in beneficial owner... | Senner Christopher J. | DORSEY & WHITNEY LLP /FA/ | 06/15/2026 | |
| 4 | Statement of changes in beneficial owner... | Lamond David | DORSEY & WHITNEY LLP /FA/ | 06/15/2026 | |
| 4 | Statement of changes in beneficial owner... | Lamond David | DORSEY & WHITNEY LLP /FA/ | 06/15/2026 | |
| 4 | Statement of changes in beneficial owner... | Senner Christopher J. | DORSEY & WHITNEY LLP /FA/ | 06/15/2026 | |
| 3 | Initial statement of beneficial ownershi... | Roberts Brigette | Quince Therapeutics, Inc. | 06/11/2026 | |
| D | Official notice of an offering of securi... | DORSEY & WHITNEY LLP /FA/ | 06/11/2026 | ||
| 4 | Statement of changes in beneficial owner... | Roberts Brigette | Quince Therapeutics, Inc. | 06/11/2026 | |
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/11/2026 | |
| No record found. | |||||
| Load More | |||||
